Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2018 Apr 5

PMID 29614816

Citations 35

Authors

Emanuela Stampone

Ilaria Caldarelli

Alberto Zullo

Debora Bencivenga

Francesco Paolo Mancini

Fulvio Della Ragione

Adriana Borriello

Affiliations

Soon will be listed here.

Abstract

The gene encodes the p57 protein which has been identified as the third member of the CIP/Kip family, also including p27 and p21. In analogy with these proteins, p57 is able to bind tightly and inhibit cyclin/cyclin-dependent kinase complexes and, in turn, modulate cell division cycle progression. For a long time, the main function of p57 has been associated only to correct embryogenesis, since -ablated mice are not vital. Accordingly, it has been demonstrated that alterations cause three human hereditary syndromes, characterized by altered growth rate. Subsequently, the p57 role in several cell phenotypes has been clearly assessed as well as its down-regulation in human cancers. lies in a genetic locus, 11p15.5, characterized by a remarkable regional imprinting that results in the transcription of only the maternal allele. The control of transcription is also linked to additional mechanisms, including DNA methylation and specific histone methylation/acetylation. Finally, long non-coding RNAs and miRNAs appear to play important roles in controlling p57 levels. This review mostly represents an appraisal of the available data regarding the control of gene expression. In addition, the structure and function of p57 protein are briefly described and correlated to human physiology and diseases.

Citing Articles

DNA Damage and Inflammatory Response of p53 Null H358 Non-Small Cell Lung Cancer Cells to X-Ray Exposure Under Chronic Hypoxia.

Nisar H, Brauny M, Labonte F, Schmitz C, Konda B, Hellweg C Int J Mol Sci. 2024; 25(23).

PMID: 39684302 PMC: 11641747. DOI: 10.3390/ijms252312590.

Knockdown of Methylation-Related Gene MBD2 Blocks Cell Growth by Upregulating p21 Expression in Head and Neck Squamous Cell Carcinoma.

Cao T, Shen X, Pei F, Jiang T, Zhang J, Zhou H Cancer Rep (Hoboken). 2024; 7(12):e70080.

PMID: 39676597 PMC: 11647173. DOI: 10.1002/cnr2.70080.

p57 Phosphorylation Modulates Its Localization, Stability, and Interactions.

Stampone E, Bencivenga D, Dassi L, Sarnelli S, Campagnolo L, Lacconi V Int J Mol Sci. 2024; 25(20).

PMID: 39456957 PMC: 11508627. DOI: 10.3390/ijms252011176.

Transcription factor YY1 adversely governs ovarian granulosa cell growth in PCOS by transcription activation-mediated CDKN1C upregulation.

Dong S, Liu Y, Yang Z Funct Integr Genomics. 2024; 24(5):171.

PMID: 39317806 DOI: 10.1007/s10142-024-01448-2.

High-resolution genome-wide mapping of chromosome-arm-scale truncations induced by CRISPR-Cas9 editing.

Lazar N, Celik S, Chen L, Fay M, Irish J, Jensen J Nat Genet. 2024; 56(7):1482-1493.

PMID: 38811841 PMC: 11250378. DOI: 10.1038/s41588-024-01758-y.

References

Lee M, DeBaun M, Mitsuya K, Galonek H, Brandenburg S, Oshimura M . Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting. Proc Natl Acad Sci U S A. 1999; 96(9):5203-8. PMC: 21842. DOI: 10.1073/pnas.96.9.5203. View

Mitsuya K, Meguro M, Lee M, Katoh M, Schulz T, Kugoh H . LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids. Hum Mol Genet. 1999; 8(7):1209-17. DOI: 10.1093/hmg/8.7.1209. View

Reynaud E, Pelpel K, Guillier M, Leibovitch M, Leibovitch S . p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts. Mol Cell Biol. 1999; 19(11):7621-9. PMC: 84790. DOI: 10.1128/MCB.19.11.7621. View

Monk D, Wakeling E, Proud V, Hitchins M, Abu-Amero S, Stanier P . Duplication of 7p11.2-p13, including GRB10, in Silver-Russell syndrome. Am J Hum Genet. 2000; 66(1):36-46. PMC: 1288348. DOI: 10.1086/302717. View

Bourcigaux N, Gaston V, Logie A, Bertagna X, Le Bouc Y, Gicquel C . High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors. J Clin Endocrinol Metab. 2000; 85(1):322-30. DOI: 10.1210/jcem.85.1.6303. View

Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M . Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science. 2000; 287(5459):1804-8. DOI: 10.1126/science.287.5459.1804. View

Reynaud E, Guillier M, Leibovitch M, Leibovitch S . Dimerization of the amino terminal domain of p57Kip2 inhibits cyclin D1-cdk4 kinase activity. Oncogene. 2000; 19(9):1147-52. DOI: 10.1038/sj.onc.1203403. View

Takahashi K, Nakayama K . Mice lacking a CDK inhibitor, p57Kip2, exhibit skeletal abnormalities and growth retardation. J Biochem. 2000; 127(1):73-83. DOI: 10.1093/oxfordjournals.jbchem.a022586. View

Hark A, Schoenherr C, Katz D, Ingram R, Levorse J, Tilghman S . CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature. 2000; 405(6785):486-9. DOI: 10.1038/35013106. View

10.

John R, Surani M . Genomic imprinting, mammalian evolution, and the mystery of egg-laying mammals. Cell. 2000; 101(6):585-8. DOI: 10.1016/s0092-8674(00)80870-3. View

11.

Shin J, Kim H, Lee K, Kim J, Park J, Won M . Mutation and expression of the p27KIP1 and p57KIP2 genes in human gastric cancer. Exp Mol Med. 2000; 32(2):79-83. DOI: 10.1038/emm.2000.14. View

12.

Oya M, Schulz W . Decreased expression of p57(KIP2)mRNA in human bladder cancer. Br J Cancer. 2000; 83(5):626-31. PMC: 2363522. DOI: 10.1054/bjoc.2000.1298. View

13.

Gartel A, Goufman E, Najmabadi F, Tyner A . Sp1 and Sp3 activate p21 (WAF1/CIP1) gene transcription in the Caco-2 colon adenocarcinoma cell line. Oncogene. 2000; 19(45):5182-8. DOI: 10.1038/sj.onc.1203900. View

14.

Nagahama H, Hatakeyama S, Nagata M, Tomita K, Nakayama K . Spatial and temporal expression patterns of the cyclin-dependent kinase (CDK) inhibitors p27Kip1 and p57Kip2 during mouse development. Anat Embryol (Berl). 2001; 203(2):77-87. DOI: 10.1007/s004290000146. View

15.

John R, Ainscough J, Barton S, Surani M . Distant cis-elements regulate imprinted expression of the mouse p57( Kip2) (Cdkn1c) gene: implications for the human disorder, Beckwith--Wiedemann syndrome. Hum Mol Genet. 2001; 10(15):1601-9. DOI: 10.1093/hmg/10.15.1601. View

16.

Castrillon D, Sun D, Weremowicz S, Fisher R, Crum C, Genest D . Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2. Am J Surg Pathol. 2001; 25(10):1225-30. DOI: 10.1097/00000478-200110000-00001. View

17.

Kassem S, Ariel I, Thornton P, Hussain K, Smith V, Lindley K . p57(KIP2) expression in normal islet cells and in hyperinsulinism of infancy. Diabetes. 2001; 50(12):2763-9. DOI: 10.2337/diabetes.50.12.2763. View

18.

Hiromura K, Haseley L, Zhang P, Monkawa T, Durvasula R, Petermann A . Podocyte expression of the CDK-inhibitor p57 during development and disease. Kidney Int. 2001; 60(6):2235-46. DOI: 10.1046/j.1523-1755.2001.00057.x. View

19.

Kikuchi T, Toyota M, Itoh F, Suzuki H, Obata T, Yamamoto H . Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors. Oncogene. 2002; 21(17):2741-9. DOI: 10.1038/sj.onc.1205376. View

20.

Li Y, Nagai H, Ohno T, Yuge M, Hatano S, Ito E . Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype. Blood. 2002; 100(7):2572-7. DOI: 10.1182/blood-2001-11-0026. View